1-8 of 8
Michelle S. Ginsberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer

Available to Purchase
Noura J. Choudhury, W. Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob Li, Isabel Preeshagul, Fernando C. Santini, Michael Offin, Kenneth Ng, Paul Paik, Christina Larsen, Michelle S. Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K. Baine, Natasha Rekhtman, Charles M. Rudin
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3697–3703.
https://doi.org/10.1158/1078-0432.CCR-23-3383
Published: 03 September 2024
View articletitled, A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
Open the PDF for A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

Open Access
Noura J. Choudhury, Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira Rizvi, Kathryn C. Arbour, Karissa Whiting, Ronglai Shen, Matthew Hellmann, Philippe L. Bedard, Celeste Yu, Natasha Leighl, Michele LeNoue-Newton, Christine Micheel, Jeremy L. Warner, Michelle S. Ginsberg, Andrew Plodkowski, Jeffrey Girshman, Peter Sawan, Shirin Pillai, Shawn M. Sweeney, Kenneth L. Kehl, Katherine S. Panageas, Nikolaus Schultz, Deborah Schrag, Gregory J. Riely, on behalf of the AACR GENIE BPC Core Team
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3418–3428.
https://doi.org/10.1158/1078-0432.CCR-23-0580
Published: 01 September 2023
View articletitled, The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
Open the PDF for The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma

Free
Marjorie G. Zauderer, Anne S. Tsao, Tao Dao, Katherine Panageas, W. Victoria Lai, Andreas Rimner, Valerie W. Rusch, Prasad S. Adusumilli, Michelle S. Ginsberg, Daniel Gomez, David Rice, Reza Mehran, David A. Scheinberg, Lee M. Krug
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7483–7489.
https://doi.org/10.1158/1078-0432.CCR-17-2169
Published: 14 December 2017
View articletitled, A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Open the PDF for A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma

Free
Mai He, Marzia Capelletti, Khedoudja Nafa, Cai-Hong Yun, Maria E. Arcila, Vincent A. Miller, Michelle S. Ginsberg, Binsheng Zhao, Mark G. Kris, Michael J. Eck, Pasi A. Jänne, Marc Ladanyi, Geoffrey R. Oxnard
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1790–1797.
https://doi.org/10.1158/1078-0432.CCR-11-2361
Published: 14 March 2012
View articletitled, EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
Open the PDF for EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker

Free
M. Catherine Pietanza, Kyuichi Kadota, Kety Huberman, Camelia S. Sima, John J. Fiore, Dyana K. Sumner, William D. Travis, Adriana Heguy, Michelle S. Ginsberg, Andrei I. Holodny, Timothy A. Chan, Naiyer A. Rizvi, Christopher G. Azzoli, Gregory J. Riely, Mark G. Kris, Lee M. Krug
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (4): 1138–1145.
https://doi.org/10.1158/1078-0432.CCR-11-2059
Published: 14 February 2012
View articletitled, Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker
Open the PDF for Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker in another window
Includes: Supplementary data
Journal Articles

Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib

Free
Yelena Y. Janjigian, Christopher G. Azzoli, Lee M. Krug, Leanne K. Pereira, Naiyer A. Rizvi, M Catherine Pietanza, Mark G. Kris, Michelle S. Ginsberg, William Pao, Vincent A. Miller, Gregory J. Riely
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2521–2527.
https://doi.org/10.1158/1078-0432.CCR-10-2662
Published: 14 April 2011
View articletitled, Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib
Open the PDF for Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib in another window
Journal Articles

A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors

Free
Christopher G. Azzoli, Lee M. Krug, Jorge Gomez, Vincent A. Miller, Mark G. Kris, Michelle S. Ginsberg, Roxanne Henry, Jessica Jones, Leslie Tyson, Megan Dunne, Barbara Pizzo, Amy Farmer, Ennapadam Venkatraman, Robert Steffen, F.M. Sirotnak
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (9): 2692–2698.
https://doi.org/10.1158/1078-0432.CCR-06-1754
Published: 01 May 2007
View articletitled, A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors
Open the PDF for A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors in another window
Journal Articles

10-Propargyl-10-deazaaminopterin: An Antifolate with Activity in Patients with Previously Treated Non-Small Cell Lung Cancer

Free
Lee M. Krug, Christopher G. Azzoli, Mark G. Kris, Vincent A. Miller, Nushmia Z. Khokhar, William Tong, Michelle S. Ginsberg, Ennapadam Venkatraman, Leslie Tyson, Barbara Pizzo, Valerie Baez, Kenneth K. Ng, F. M. Sirotnak
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2072–2078.
Published: 01 June 2003
View articletitled, 10-Propargyl-10-deazaaminopterin: An Antifolate with Activity in Patients with Previously Treated Non-Small Cell Lung Cancer
Open the PDF for 10-Propargyl-10-deazaaminopterin: An Antifolate with Activity in Patients with Previously Treated Non-Small Cell Lung Cancer in another window